How to prevent hair loss is a question that concerns millions of people across the UK, affecting men and women of all ages. Hair loss can stem from a wide range of causes — from hereditary androgenetic alopecia and nutritional deficiencies to autoimmune conditions and medication side effects. Understanding the underlying cause is essential before choosing the right prevention or treatment strategy. This article outlines the most common causes of hair loss in the UK, when to seek medical advice, evidence-based prevention methods, available NHS and private treatments, and the lifestyle and nutritional factors that support healthy hair growth.

Common Causes of Hair Loss in the UK

Androgenetic alopecia is the most common cause of hair loss in the UK, but telogen effluvium, alopecia areata, thyroid disorders, iron deficiency, and traction alopecia are also frequently encountered.

Not sure if this is normal? Chat with one of our pharmacists →

Hair loss is a widespread concern in the UK, affecting both men and women across all age groups. Understanding the underlying cause is the essential first step in knowing how to prevent hair loss effectively. The most common form is androgenetic alopecia (male- or female-pattern baldness), a hereditary condition driven by sensitivity to dihydrotestosterone (DHT), a derivative of testosterone. In women, this pattern is often associated with hyperandrogenism or polycystic ovary syndrome (PCOS). Androgenetic alopecia accounts for the majority of hair loss cases seen in primary care.

Beyond genetics, several other causes are frequently encountered:

• Telogen effluvium – a temporary, diffuse shedding often triggered by physical or emotional stress, illness, surgery, significant weight loss, or childbirth (postpartum telogen effluvium is particularly common). It typically occurs two to three months after the triggering event.

• Alopecia areata – an autoimmune condition in which the immune system mistakenly attacks hair follicles, causing patchy hair loss. It is estimated to affect around 2% of people in the UK at some point in their lives (NHS).

• Thyroid disorders – both hypothyroidism and hyperthyroidism can disrupt the hair growth cycle, leading to diffuse thinning.

• Iron deficiency anaemia – particularly common in women of reproductive age, low ferritin levels are a well-recognised contributor to hair shedding.

• Scalp conditions – such as tinea capitis (ringworm of the scalp) or seborrhoeic dermatitis. Tinea capitis is more common in children, requires prompt systemic antifungal treatment, and can cause scarring alopecia if left untreated. Seborrhoeic dermatitis is more commonly associated with temporary shedding rather than direct follicle damage.

• Traction alopecia – caused by persistent tension on the hair from tight hairstyles; this can progress to permanent follicle damage if not addressed.

• Trichotillomania – a compulsive urge to pull out one's own hair, which warrants psychological support alongside any hair-focused management.

Certain medicines, including anticoagulants, retinoids, and some antidepressants, are also associated with hair loss as a side effect. Identifying whether hair loss is patterned, patchy, or diffuse helps clinicians narrow down the diagnosis and guide appropriate management.

When to See a GP About Hair Loss

See a GP if hair loss is sudden, patchy, or accompanied by symptoms such as fatigue, scalp inflammation, or signs of hormonal imbalance, as these may indicate a treatable underlying condition.

Whilst some degree of hair shedding is entirely normal — losing between 50 and 100 hairs per day is considered within the typical range — there are circumstances in which seeking medical advice is strongly recommended. Consulting a GP is particularly important when hair loss is sudden, rapid, or accompanied by other symptoms, as this may indicate an underlying medical condition requiring investigation.

You should contact your GP if you notice:

• Sudden or patchy hair loss appearing over a short period

• Hair loss accompanied by fatigue, unexplained weight changes, or skin changes (which may suggest a thyroid disorder)

• Signs of hyperandrogenism in women, such as irregular periods, acne, or unwanted facial or body hair, which may indicate PCOS and warrant endocrine assessment

• Scalp redness, scaling, itching, or visible inflammation

• Hair loss following a new medicine — do not stop prescribed medication without medical guidance

• Significant psychological distress related to hair loss, which can affect mental health and quality of life

• Hair loss in children, particularly if accompanied by scalp scaling, broken hairs, or swollen lymph nodes — this needs prompt assessment to exclude tinea capitis, which requires systemic antifungal treatment

Your GP will typically take a thorough history and may arrange blood tests based on clinical suspicion. Tests commonly considered include full blood count, ferritin, and thyroid function; vitamin D and other tests are generally reserved for situations where deficiency or specific risk factors are suspected, in line with NICE CKS guidance on hair loss. A referral to a dermatologist may be made if the diagnosis is unclear or if a condition such as alopecia areata is suspected.

Suspected scarring alopecia (such as lichen planopilaris or frontal fibrosing alopecia) warrants prompt referral to dermatology, as these conditions can permanently destroy follicles and early treatment is important to preserve remaining hair. There is no need to feel embarrassed about raising hair loss concerns with a healthcare professional — it is a clinically recognised condition with a range of effective management options.

Evidence-Based Ways to Prevent Hair Loss

The most effective prevention targets the underlying cause; for androgenetic alopecia, early use of topical minoxidil and avoiding damaging hair practices have the strongest evidence base.

Preventing hair loss depends largely on its cause, but several evidence-based strategies can help maintain follicle health and slow progression, particularly in androgenetic alopecia and lifestyle-related shedding.

Addressing the root cause is the most effective preventive measure. For example, correcting iron deficiency or optimising thyroid function through appropriate medical treatment can significantly reduce hair shedding. Similarly, managing stress through recognised techniques — such as cognitive behavioural therapy (CBT), mindfulness, or regular physical activity — may help manage triggers associated with telogen effluvium, though direct evidence that stress reduction prevents episodes is limited.

For those with androgenetic alopecia, early intervention is key, as hair follicles gradually miniaturise over time. The following approaches have the strongest evidence base:

• Minoxidil (topical) – available over the counter in the UK, minoxidil is thought to support the anagen (growth) phase of the hair cycle and increase follicle size, though its exact mechanism of action is not fully understood (MHRA/EMC SmPC). It is licensed for use in both men and women and is most effective when started early. Common side effects include scalp irritation and unwanted facial hair growth (hypertrichosis). Women who are pregnant or breastfeeding should seek medical advice before use and read the Patient Information Leaflet carefully.

• Avoiding damaging hair practices – excessive heat styling, tight hairstyles (which can cause traction alopecia), chemical treatments, and aggressive brushing can all worsen hair fragility and loss.

• Scalp hygiene – keeping the scalp clean and managing seborrhoeic dermatitis or dandruff using appropriate medicated shampoos may support a healthier follicular environment. Products containing ketoconazole, selenium sulphide, coal tar, or piroctone olamine are available in the UK; note that zinc pyrithione has been removed from most UK and EU cosmetic shampoos and is no longer widely available in this context.

• Gentle hair care – using wide-toothed combs, avoiding tight ponytails, and allowing hair to air-dry where possible reduces mechanical stress on the hair shaft.

It is worth noting that no single approach guarantees prevention, and results vary between individuals. Consistency and realistic expectations are important when embarking on any hair loss prevention strategy.

If you experience a suspected side effect from any medicine or topical product used for hair loss, you can report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

Experiencing these side effects? Our pharmacists can help you navigate them →

Treatments Available on the NHS and Privately

NHS treatment focuses on medically significant causes, including corticosteroids for alopecia areata; finasteride and oral minoxidil are available privately but carry important safety considerations.

A range of treatments is available in the UK for hair loss, spanning NHS provision and private options. The appropriate treatment depends on the confirmed diagnosis, severity, and individual patient factors.

NHS-available treatments are generally focused on medically significant causes of hair loss:

• Minoxidil (topical) – whilst available over the counter, GPs may recommend it as part of a management plan for androgenetic alopecia. It is not routinely prescribed on the NHS for cosmetic hair loss.

• Finasteride – an oral 5-alpha reductase inhibitor licensed for male-pattern baldness. It works by reducing the conversion of testosterone to DHT, thereby slowing follicle miniaturisation. It is not available on NHS prescription for hair loss but can be obtained privately. Important safety information: finasteride is associated with sexual dysfunction (including decreased libido and erectile dysfunction), and with psychiatric effects including depression and, rarely, suicidal ideation. Some of these effects may persist after stopping treatment. Finasteride also lowers PSA (prostate-specific antigen) levels, which must be taken into account when interpreting PSA tests for prostate cancer screening. Patients should be provided with and asked to read the MHRA patient alert card before starting treatment, and should discuss the risks and benefits fully with their prescriber. Finasteride is contraindicated in women, particularly those of childbearing potential, due to the risk of harm to a male foetus.

• Corticosteroids – for alopecia areata, intralesional corticosteroid injections or topical steroid preparations may be offered via dermatology on the NHS to suppress the autoimmune response.

• Immunotherapy (diphencyprone/DPCP) – used in specialist dermatology centres for extensive alopecia areata, this treatment is available on the NHS in some regions.

• JAK inhibitors (e.g., baricitinib) – baricitinib is now licensed in the UK for severe alopecia areata in adults. NHS availability depends on NICE approval and local commissioning decisions; a dermatology referral is required to explore eligibility.

Privately available options include:

• Oral minoxidil – used off-label at low doses under medical supervision, with emerging evidence supporting its efficacy. It is important to note that oral minoxidil is not licensed for hair loss in the UK. It carries cardiovascular risks including fluid retention, oedema, tachycardia, hypotension, and, rarely, pericardial effusion. It should only be used under the supervision of a qualified clinician with appropriate monitoring, and is not suitable for self-medication.

• Anti-androgens for women – medicines such as spironolactone may be considered off-label for female-pattern hair loss under specialist care, with appropriate monitoring and reliable contraception, as these medicines must be avoided in pregnancy.

• Platelet-rich plasma (PRP) therapy – involves injecting concentrated growth factors from the patient's own blood into the scalp. Evidence is promising but not yet conclusive.

• Hair transplant surgery – a surgical option for suitable candidates with stable androgenetic alopecia, this is usually only available privately for pattern hair loss; NHS funding may be considered in select reconstructive cases.

The MHRA regulates all licensed medicines in the UK. Patients should ensure any private treatment is provided by a qualified, registered healthcare professional, and should report any suspected adverse drug reactions via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

Lifestyle and Nutritional Factors That Affect Hair Health

Correcting iron deficiency and maintaining adequate vitamin D and dietary protein supports hair health, though supplements should only be taken for confirmed deficiencies rather than routinely.

Hair follicles are among the most metabolically active structures in the body, making them particularly sensitive to nutritional deficiencies and lifestyle factors. Whilst diet alone is unlikely to reverse significant hair loss, optimising nutritional status plays a meaningful supporting role in maintaining hair health and reducing excess shedding.

Key nutrients associated with hair growth include:

• Iron and ferritin – low ferritin (stored iron) is one of the most common nutritional contributors to hair loss in women. The NHS recommends dietary sources such as red meat, lentils, spinach, and fortified cereals. Supplementation should only be undertaken following a confirmed blood test, as excess iron carries its own risks.

• Vitamin D – deficiency has been associated with alopecia areata and telogen effluvium, though a direct causal relationship is not fully established. Safe sun exposure and dietary sources (oily fish, eggs, fortified foods) are recommended. The NHS advises that everyone in the UK consider a daily vitamin D supplement during autumn and winter months, and that those at higher risk of deficiency take a supplement year-round.

• Biotin (Vitamin B7) – widely marketed for hair health, though clinical evidence for supplementation in those without a confirmed deficiency is limited. True biotin deficiency is rare in the UK. Importantly, high-dose biotin supplements can interfere with a range of laboratory immunoassays — including thyroid function tests and troponin — potentially producing falsely abnormal results (MHRA Drug Safety Update). If you take biotin supplements, inform your GP or the laboratory before any blood tests.

• Zinc and protein – adequate dietary protein (found in meat, fish, eggs, legumes, and dairy) is essential for keratin production. Zinc deficiency, though uncommon, can contribute to hair shedding.

Supplements should be targeted at confirmed deficiencies rather than taken routinely; unnecessary supplementation is unlikely to benefit hair health and may carry risks.

Lifestyle factors also play a significant role. Chronic psychological stress can disrupt the hair growth cycle and is associated with telogen effluvium. Smoking has been associated with earlier onset and greater severity of androgenetic alopecia, though the precise mechanism has not been fully established. Excessive alcohol consumption may deplete key nutrients and affect hormonal balance.

A balanced, varied diet in line with the NHS Eatwell Guide, combined with stress management and avoidance of harmful habits, provides a sound foundation for supporting hair health alongside any medical treatment.

Frequently Asked Questions